Acquired haemophilia: a case report and a clinical review

作者: Lucia Todaro , Giuseppe Leone , Mauro Girotto , Pierdomenico Bertello

DOI: 10.4081/ITJM.2009.47

关键词:

摘要: BACKGROUND Acquired haemophilia presents later in life and is due to acquired inhibitors factor VIII. The disorder very rare (about one case per million population year) but causes significant morbidity mortality. CASE REPORT We report the of a 57 year-old obese man who was admitted our Day Hospital for anemia. At admission we observed diffuse ecchymoses large subcutaneous hematoma inferior right hemithorax. Laboratory findings showed severe anemia, prolonged aPTT with normal PT platelet count. titer anti-factor VIII inhibitor Bethesda units resulted high confirmed diagnosis haemophilia. used recombinant activated VII (rFVIIa) control active bleeding prednisone, cyclophosphamide and, lastly, anti- CD 20 monoclonal antibody (rituximab) eliminate inhibitors. Unfortunately, on fourth week, patient suffered an extensive abdominal wall died. CONCLUSIONS underline importance not overlooking because bleedings associated can be life-threatening constitute medical emergency.

参考文章(11)
David Green, Klaus Lechner, A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thrombosis and Haemostasis. ,vol. 45, pp. 200- 203 ,(1981) , 10.1055/S-0038-1650169
Suman L. Sood, Craig M. Kessler, Acquired Inhibitors to Factor VIII Wiley‐Blackwell. pp. 86- 90 ,(2007) , 10.1002/9781444318555.CH12
Mario Von Depka, NovoSeven: mode of action and use in acquired haemophilia. Intensive Care Medicine. ,vol. 28, ,(2002) , 10.1007/S00134-002-1469-1
D. Söhngen, C. Specker, D. Bach, B. M. E. Kuntz, M. Burk, C. Aul, G. Kobbe, A. Heyll, K. A. Hollmig, W. Schneider, Acquired factor VIII inhibitors in nonhemophilic patients. Annals of Hematology. ,vol. 74, pp. 89- 93 ,(1997) , 10.1007/S002770050263
Charles R.M. Hay, 1 Acquired haemophilia Baillière's clinical haematology. ,vol. 11, pp. 287- 303 ,(1998) , 10.1016/S0950-3536(98)80049-8
A. Aggarwal, R. Grewal, R. J. Green, L. Boggio, D. Green, B. B. Weksler, A. Wiestner, G. P. Schechter, Rituximab for autoimmune haemophilia: a proposed treatment algorithm. Haemophilia. ,vol. 11, pp. 13- 19 ,(2005) , 10.1111/J.1365-2516.2005.01060.X
A. E. Morrison, C. A. Ludlam, Acquired haemophilia and its management. British Journal of Haematology. ,vol. 89, pp. 231- 236 ,(1995) , 10.1111/J.1365-2141.1995.TB03294.X
Alice D. Ma, Daniel Carrizosa, Acquired factor VIII inhibitors: pathophysiology and treatment. Hematology. ,vol. 2006, pp. 432- 437 ,(2006) , 10.1182/ASHEDUCATION-2006.1.432
Aledort L, Green D, Aronson D, Hampton J, Fratantoni J, Edson, van Eys J, Lazerson J, Counts R, Kasper Ck, McMillan C, Shapiro S, Penner J, Levine P, Hilgartner M, Shulman Nr, Proceedings: A more uniform measurement of factor VIII inhibitors. Thrombosis et diathesis haemorrhagica. ,vol. 34, pp. 612- 612 ,(1975)